Knowledge Base - Massachusetts Biotechnology Council - Massachusetts Biotechnology Council

Technology Readiness March 29, 2017 in White Papers

New product development efforts are a significant investment. If product development is initiated before the technology is ready, time and money can be wasted while technology problems are addressed. Read More

Medical Device Commercialization 101 March 29, 2017 in White Papers

The path from concept to commercialization is a complex process. Sunrise Labs has prepared an outline of the medical device commercialization process as an overview of the efforts required. Read More

WEBINAR: Critical Drug Substance Considerations for Formulation Success in Drug Product Development Alcami March 27, 2017 in Training Sessions

Understanding the solid state properties of a drug candidate molecule is of critical importance for successful dosage form development. Read More

Jonathan Hart, Senior Fire Protection Engineer at NFPA® talks about NFPA 99 classroom training and how it relates to the CMS announcement National Fire Protection Association March 27, 2017 in Presentation & Video Library,

Federal Issues

In this video, Jonathan Hart, Senior Fire Protection Engineer at NFPA talks about NFPA 99 classroom training and how it relates to the CMS announcement. Read More

NFPA Health Care Section National Fire Protection Association March 27, 2017 in Advisories

NFPA members are invited to maximize their membership benefits by joining one or more of our industry-specific Member Sections. Section membership is FREE and included with your NFPA membership. Read More

Data Visualization: The Epilepsy Story Eliassen Group March 20, 2017 in White Papers,

Biomanufacturing

An exploratory analysis and the visualization of data for clarity around epilepsy. Read More

Biomarker Use Facilitated by CDISC Standards Eliassen Group March 20, 2017 in White Papers,

Biomanufacturing

The value of biomarkers to develop patient groups based on clinical response to treatment. Read More

White Paper: Abuse-Deterrent Studies for Controlled Drugs – A Changing Landscape Alcami March 13, 2017 in White Papers

Engineering abuse-deterrent properties into prescription forms of drugs with abuse potential has become a primary strategy for abuse prevention. Read More

Elemental Impurities: The Risk-Based Approach Alcami March 13, 2017

The U.S. Pharmacopeia (USP) intends to remove the existing wet chemistry heavy metals methods outlined in USP General Chapter by January 2018. Read More

Staying Financially Focused During Uncertain Times Freedom Trail Financial March 9, 2017

Uncertainty is not a new concept within the life sciences sector. So how do you make long-term financial decisions when there is no clear outlook for the sector in which you work? Read More